Patents by Inventor Manjusha Malhotra

Manjusha Malhotra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combinations of glimepiride and the thiazolidinedione for treatment of diabetes
    Publication number: 20040147564
    Abstract: A unit-dose pharmaceutical composition for the treatment of non-insulin dependent diabetes mellitus includes a combination of glimepiride and a thiazolidinedione insulin sensitizer, providing for the simultaneous release of each drug at rates substantially similar to those obtained with the separate administration of immediate release dosage forms of glimepiride and the thiazolidinedione. In addition, processes for the preparation of such combination unit-dose compositions and the use of such compositions for improving glycemic control are described.
    Type: Application
    Filed: August 16, 2003
    Publication date: July 29, 2004
    Inventors: Vinay U. Rao, Dilip Gopalkrishna Saoji, Sunil Anantrao Mirajkar, Prashant Prabhakarrao Deshmukh, Harshal Prabhakar Bhagwatwar, Manjusha Malhotra, Milind C. Shukla, Noel John De Souza
  • Multiparticulate compositions for once-a-day administration
    Publication number: 20030219482
    Abstract: A pharmaceutical composition suitable for a once-a-day dosing regimen includes a combination of a biguanide and a sulfonylurea in the form of a multiparticulate, polyphasic system for the treatment of non-insulin dependent diabetes mellitus (NIDDM) and for improving glycemic control.
    Type: Application
    Filed: March 20, 2003
    Publication date: November 27, 2003
    Inventors: Sunil Sudhakar Chaudhari, Dilip Gopalkrishna Saoji, Harshal Prabhakar Bhagwatwar, Manjusha Malhotra, Milind C. Shukla, Noel John De Souza
  • Oral compositions for treatment of diabetes
    Publication number: 20030187074
    Abstract: An oral delivery system for the treatment of non-insulin dependent diabetes mellitus in humans includes a pharmaceutically effective amount of a biguanide and a water-insoluble polymeric carrier, providing for a controlled release of the biguanide independent of environmental pH. In addition, a layer including a glitazone or sulfonylurea can be included in the oral delivery system, while still providing for a pH-independent, controlled release of biguanide over an extended period of time.
    Type: Application
    Filed: March 3, 2003
    Publication date: October 2, 2003
    Inventors: Javed Hussain, Parag Prakash Borde, Harshal Prabhakar Bhagwatwar, Manjusha Malhotra, Milind C. Shukla, Noel John De Souza